サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：動物用ワクチンの世界市場-2023-2030
市場調査レポート
商品コード
1285061

動物用ワクチンの世界市場-2023-2030

Global Animal Vaccine Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
動物用ワクチンの世界市場-2023-2030
出版日: 2023年06月05日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場の概要

世界の動物用ワクチン市場は、2022年に120億8,920万米ドルに達し、2030年には最大224億430万米ドルに達することで有利な成長を遂げると予測されます。世界の動物用ワクチン市場は、予測期間（2023年～2030年）に8.2%のCAGRを示すと予測されています。

ワクチン接種は、動物の健康と幸福を維持するために不可欠です。ワクチン接種は、農作物や家畜の疾病負担を軽減する効果的な方法であることが長い間証明されています。動物の健康と病気の予防プログラムは、予防接種にますます依存するようになりました。

動物用ワクチンの世界市場は、研究開発の増加や各国での医療認可の予定などの要因により拡大しており、動物用ワクチン市場の成長にも明るい見通しが立っています。また、動物の飼育数の増加や、新規ワクチンの臨床試験の増加も、動物用ワクチンの市場動向に対する需要を押し上げています。

市場力学

研究開発の活発化が動物用ワクチン市場の成長を促進する

動物用ワクチンの分野では、さまざまな新規研究開発が行われています。EUからの資金援助を受けて研究者たちが生み出した新しい家畜用ワクチンは、抗生物質耐性を最小限に抑え、動物福祉を向上させ、費用を節約し、環境に悪影響を与える化学物質の必要性を減らす可能性を秘めています。EUが資金提供したSAPHIRプロジェクトは、新鮮で強力な予防接種を作成することで、動物の病気予防のギャップを解決しようと努力しました。

研究者たちは、経済的損失が大きく、抗生物質による治療が強く求められる疾患に焦点を当てました。SAPHIRの研究者は、最新のゲノムおよび生物統計学的アプローチを用いて、ワクチンへの高い反応を取り入れた育種技術を確立するためのバイオマーカーを特定しました。

また、数理モデル技術を用いて、ワクチンが実際にどの程度効くかを予測しています。最近発見された疾病株に対して幅広い免疫を提供できるワクチン候補を、最先端技術を駆使して作り出しました。プロジェクト終了時には、豚、鶏、牛に影響を与える6つの重要な家畜感染症に対する動物用ワクチン候補を作製しています。したがって、研究の進展が動物用ワクチン市場規模を牽引しています。

政府のイニシアチブの高まりと新製品の発売が、メーカーに有利な機会を創出する

動物用ワクチンの市場機会は、進歩や規制当局の承認の高まり、感染症の蔓延の増加によって拡大しています。また、主要メーカーによる新規製品の発売も市場を牽引しています。

動物用医薬品登録のための技術基準の調和を目的とした欧州連合・日本・米国の3者間プログラム「動物用医薬品登録のための技術基準の調和に関する国際協力（VICH）」など、数多くの政府・非政府組織による取り組みが行われています。

VICHの責務は、動物用医薬品の販売承認に必要な情報の技術基準を標準化することです。これは、販売許可申請書に記載しなければならない調査について統一基準を設けることで達成されます。

動物の健康に対する意識の欠如が市場成長の妨げになる

動物が不健康になると、さまざまな悪影響が出るため、動物の健康は極めて重要です。さらに、人間に影響を及ぼす動物の病気は、世界貿易、農業の安定、公衆衛生など、他の経済分野にも影響を及ぼす可能性があります。したがって、上記の要因は、予測期間中の動物健康市場の成長を制限することになります。

COVID-19の影響分析

COVID-19のパンデミックと世界各国の封鎖により、あらゆる業種の企業の財務の健全性が影響を受けています。そのため、COVID-19公衆衛生緊急事態の期間中、米国食品医薬品局（FDA）は、スポンサーや研究者を支援するための一般的な考慮事項、試験参加者の安全確保、優良臨床試験（GCP）の遵守、動物に対する試験の完全性へのリスクの最小化などを含むガイドラインを発表しました。

ロシア・ウクライナ紛争影響分析

ロシア・ウクライナ紛争は、この地域の主要な市場プレイヤーの数が少ないため、世界の動物用ワクチン市場に与える影響は少ないと推定されます。しかし、原材料の輸出入の影響は、予測期間中、世界の動物用ワクチン市場の成長にほとんど影響を及ぼさないと予想されます。

目次

第1章 調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

  • 製品タイプ別スニペット
  • 動物種別スニペット
  • 投与経路別
  • 地域別スニペット

第4章 市場力学

  • 影響要因
    • 促進要因
      • 動物用ワクチン製造における技術革新の進展
      • 研究開発の活発化
    • 抑制要因
      • 動物の健康に対する意識の欠如
    • 機会
      • 規制当局の承認と新製品発売の増加
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • 価格分析
  • 法規制の分析

第6章 COVID-19の分析

  • COVID-19の分析
    • COVID-19の前のシナリオ
    • COVID-19期間中のシナリオ
    • COVID-19後のシナリオと今後のシナリオ
  • COVID-19の中での価格・ダイナミクス
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • サマリー

第7章 製品タイプ別

  • 弱毒生ワクチン（Modified-live Vaccine
  • 不活化（死滅）ワクチン
  • 遺伝子組換えワクチン
  • トキソイドワクチン

第8章 動物種別

  • コンパニオンアニマル
    • ネコ
    • イヌ
    • その他
  • 畜産動物
    • 家禽
    • 豚
    • 牛
    • その他
  • 水産養殖

第9章 投与経路別

  • 皮下投与
  • 筋肉内
  • 鼻腔内

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
      • その他アジア太平洋地域
  • 中東・アフリカ地域
    • 地域別の主なダイナミクス

第11章 競合情勢

  • 競合シナリオ
  • 市況ポジショニング/シェア分析
  • M&A（合併・買収）分析

第12章 企業プロファイル

  • Merck & Co., Inc.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展状況
  • Boehringer Ingelheim International GmbH
  • Zoetis Services LLC
  • Ceva
  • Vetoquinol
  • Elanco
  • Veterquimica S.A.
  • Phibro Animal Health Corporation
  • KBNP, Inc.
  • Kyoto Biken Laboratories, Inc.

第13章 付録

目次
Product Code: VH6437

Market Overview

The global animal vaccine market reached US$ 12,089.2 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 22,404.3 million by 2030. The global animal vaccine market is expected to exhibit a CAGR of 8.2% during the forecast period (2023-2030).

Vaccination is vital in preserving animal health and well-being. It has long been proven to be an effective method of lowering disease burden in farm and domestic animals. Animal health and illness prevention programs continue to depend more and more on vaccinations.

The global market for animal vaccines is expanding as a result of factors including increasing research and development and their upcoming medical approvals across countries are also creating a positive outlook for the animal vaccine market growth. The increasing adoption of animals and the growing clinical trials for novel vaccines are also driving up demand for animal vaccine market trends.

Market Dynamics

The Rising Research and Development Drive the Growth of the Animal Vaccine Market

Various novel research and developments are being done in the field of animal vaccines. New livestock vaccinations created by researchers with funding from the EU have the potential to minimize antibiotic resistance, increase animal welfare, save money, and lessen the need for chemicals that harm the environment. The EU-funded SAPHIR project made an effort to address the gaps in animal illness prevention by creating fresh, potent vaccinations.

The researchers focused on conditions that cause significant economic losses and a strong demand for antibiotic treatments. Researchers from SAPHIR have identified biomarkers for establishing breeding techniques that incorporate high response to vaccines using the most recent genomic and biostatistical approaches.

In addition, they have used mathematical modeling techniques to forecast how well vaccines will work in practice. They have created vaccination candidates using cutting-edge technologies that can offer wide immunity against recently discovered disease strains. The team has produced animal vaccine candidates for six important livestock infections that impact pigs, chickens, and cattle at the project's conclusion. Hence, the growing research is driving the animal vaccine market size.

Rising Government Initiatives and Novel Product Launches Creates Lucrative Opportunities for Manufacturers

There is a growing animal vaccine market opportunity owing to rising advancements and regulatory approvals and the increasing prevalence of infectious diseases. The rising novel product launches by major key players is also driving the market.

Actions are taken by numerous governmental and non-governmental organizations, such as the trilateral European Union-Japan-US program International Cooperation on Harmonization of Technical Standards for Registration of Veterinary Medicinal Products (VICH), which aims to harmonize the technical specifications for veterinary product registration.

VICH's responsibility is to standardize the technical standards for the information required for a veterinary medical product's marketing authorization. This is accomplished by creating unified standards for the research that must be included in a marketing permission application.

A Lack of Animal Health Awareness will Hamper the Growth of the Market

Animal health is crucial because unhealthy animals can have a wide range of negative effects. Additionally, animal diseases that affect humans can have an effect on other economic sectors such as global trade, agricultural stability, and public health. Hence, the above-mentioned factors will be limiting the animal health market growth over the forecast period.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity for animals.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global animal vaccine market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global animal vaccine market growth over the forecast period.

Segment Analysis

The global animal vaccine market is segmented based on product type, animal type, route of administration and region.

Inactivated Vaccines From Product Type Segment Account for 40.3% of the Market Share Owing to Rising Novel Product Launches

In 2022, the inactivated vaccines segment held a dominant position in the global animal vaccine market. The segment is advantageous because inactivated vaccinations, also known as killed vaccines, are made by killing a pathogen that has been grown and then turned into a vaccine. These vaccines are often used to protect against a variety of bacterial and viral illnesses.

Furthermore, inactivated vaccines elicit powerful immune responses by retaining the inactive genetic element, and the virus surface antigens are essential for a powerful immunological response. Additionally, inactivated immunization is safe and has a higher demand because it doesn't remain in the surroundings or in the fish who have received it.

As a result, there is now a greater need for inactivated aquaculture vaccinations. The market segment is predicted to have the greatest market share during the projection period based on the aforementioned assertions.

Geographical Analysis

North America Accounted For Approximately 39.8% of the Market Share Owing to the Strong Presence of Major Players and Increasing Technological Advancements

Manufacturers have chances to expand their operations in this region because of the rising demand for animal vaccines for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of animal vaccines, which has increased the demand. North America has a large number of producers and suppliers, and as a result of the swift economic development of the area, industrial production has increased, fueling the demand for animal vaccines.

Rising new drug or infection types will drive market growth. Growth is also fueled by rising technological advancements, regulatory approvals, and novel product launches. Researchers are becoming more aware of various kinds of treatment or prevention approaches for infectious disorders, leading to the expansion of the market in this region. These factors shows the dominance of North America.

Competitive Landscape

The major global players in the animal vaccine market include: Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Services LLC, Ceva, Vetoquinol, Elanco, Veterquimica S.A., Phibro Animal Health Corporation, KBNP, Inc. and Kyoto Biken Laboratories, Inc. among others.

Why Purchase the Report?

  • To visualize the global animal vaccine market segmentation based on product type, animal type, route of administration and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of animal vaccine market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global animal vaccine market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Animal Type
  • 3.3. Snippet by Route of Administration
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Innovation in Animal Vaccine Production
      • 4.1.1.2. The Rising Research and Development
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Animal Health Awareness
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Regulatory Approvals and Novel Product Launches
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Post COVID-19 & Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Modified-live (attenuated) Vaccine *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Inactivated (killed) Vaccine
  • 7.4. Recombinant Vaccine
  • 7.5. Toxoid Vaccine

8. By Animal Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 8.1.2. Market Attractiveness Index, By Animal Type
  • 8.2. Companion Animal *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Feline
    • 8.2.4. Canine
    • 8.2.5. Others
  • 8.3. Livestock Animal
    • 8.3.1. Poultry
    • 8.3.2. Swine
    • 8.3.3. Cattle
    • 8.3.4. Others
  • 8.4. Aquaculture

9. By Route of Administration

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
    • 9.1.2. Market Attractiveness Index, By Route of Administration
  • 9.2. Subcutaneous *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Intramuscular
  • 9.4. Intranasal

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Merck & Co., Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Boehringer Ingelheim International GmbH
  • 12.3. Zoetis Services LLC
  • 12.4. Ceva
  • 12.5. Vetoquinol
  • 12.6. Elanco
  • 12.7. Veterquimica S.A.
  • 12.8. Phibro Animal Health Corporation
  • 12.9. KBNP, Inc.
  • 12.10. Kyoto Biken Laboratories, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us